Asphalion   Report issue

For profit Phase 2 Phase 3
Founded: Barcelona Spain (2000)

Organization Overview

First Clinical Trial
2017
NCT02888756
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Asphalion

Active Ingredients

Drugs in Phase 3 Trials (1)

phenoxymethylpenicillin (1 trial)

Drugs in Phase 2 Trials (5)

alprostadil (prostin) (1 trial)

ihivarna (1 trial)

papaverine (1 trial)

phentolamine mesylate (regitine) (1 trial)

trimix (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6